CatalYm jobs and careers

catalym.com LinkedIn

See 6 open roles

6Open roles

2Posted in the last 7 days

About CatalYm

CatalYm is a biotechnology company developing innovative immunotherapies for cancer patients.

Founded in 2016 by Jörg Wischhusen.

Biotechnology Health Care Medical Therapeutics

Founded: 2016
Employees: 11 to 50
Total funding: $260.9M

Leadership

The top of CatalYm's org chart, with how many people report into each leader.

Eugen Leo

Chief Medical Officer

7 reports

Thorsten Ross

VP Translational Biology

5 reports

Petra Fettes

Senior Vice President, Head Clinical Operations

4 reports

Anne Burger

CFO & CEO Ad Interim

2 reports

María Cecilia González

Senior Scientist

2 reports

Sabrina Genßler

Director - Translational Research & Clinical Bioanalytics

1 report

Julia Kruschel

VP Regulatory Affairs

Jonathan Tobin

Non Executive Director

Felix Lichtenegger

Vice President Clinical Development

2 reports

Riham Elbadri

Head Of Drug Safety

2 reports

Lena Dr. Lemke

Medical Director

Marlene Auer

Senior Scientist Translational Research And Bioanalytics

1 report

Ulrich Kronthaler

Director Preclinical Development

1 report

José Medina Echeverz

Executive Director Discovery Biology

Gabriele Zacke

Director Clinical Operations

1 report

Vanja Radulovic

Senior Clinical Trial Manager

Board

Rogier Rooswinkel

Board Member

Nathalie Weitemeyer

Board Member

Oskar Slotboom

Board Member

Marianne Uteng

Board Member

Jonathan Tobin

Board Member

Andreas Wallnöfer

Board Member

About CatalYm

Leadership

Board

Open roles at CatalYm 6